Myrtaven
Myrtaven is a medicine authorised by Swissmedic under authorisation number 49506. The authorisation holder is IBSA Institut Biochimique SA. The medicinal product code is Herbal medicines and the dispensing category is B: Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly. First authorisation was granted on 05 September 1988 and the authorisation is valid without a time limit. ATC code C05CX places the medicine in the group Vasoprotectives.
| Authorisation number | 49506 |
|---|---|
| Name | Myrtaven |
| Full name | Myrtaven, capsule |
| Authorisation holder | IBSA Institut Biochimique SA |
| Medicinal product code | Herbal medicines |
| Dispensing category | B · Prescription only |
| ATC code | C05CX |
| First authorisation | 05 September 1988 |
| Authorisation validity | unlimited |
| No. | Name | Dispensing category | Authorisation date |
|---|---|---|---|
| 2 | Myrtaven, capsule | B | 12 May 1997 |
Scroll the table sideways
| Pack code | Quantity | Unit | ATC | IT code | Dispensing category |
|---|---|---|---|---|---|
| 58 | 60 | Kapsel(n) | C05CX | 02.08.1. | B |
Scroll the table sideways
Medicines in the same ATC group
Other medicines from this authorisation holder
Frequently asked questions
Is Myrtaven authorised in Switzerland?
Yes. Myrtaven is authorised by Swissmedic under authorisation number 49506, data as of 01 September 2026. The authorisation is valid without a time limit.
Which dispensing category does Myrtaven have?
Myrtaven is in dispensing category B. Supplied only against a prescription which, at the prescriber's discretion, may be dispensed repeatedly.
Who is the authorisation holder of Myrtaven?
The authorisation holder is IBSA Institut Biochimique SA. The holder carries the legal responsibility for quality, safety and product information of the medicine in Switzerland.
Sources
Swissmedic data as of 01 September 2026. No medical advice. Independent directory, not affiliated with Swissmedic or the FOPH.